Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

Helicobacter pylori resistance to antibiotics in Europe and its relationship to antibiotic consumption

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

DOI

  • Francis Megraud
  • Samuel Coenen
  • Ann Versporten
  • Manfred Kist
  • Manuel Lopez-Brea
  • Alexander M Hirschl
  • Leif P Andersen
  • Herman Goossens
  • Youri Glupczynski
  • on behalf of the Study Group participants
  • Lone Rasmussen
Vis graf over relationer
OBJECTIVE: Resistance to antibiotics is the major cause of treatment failure of Helicobacter pylori infection. A study was conducted to assess prospectively the antibacterial resistance rates of H pylori in Europe and to study the link between outpatient antibiotic use and resistance levels in different countries. DESIGN: Primary antibiotic resistance rates of H pylori were determined from April 2008 to June 2009 in 18 European countries. Data on yearly and cumulative use over several years of systemic antibacterial agents in ambulatory care for the period 2001-8 were expressed in Defined Daily Doses (DDD) per 1000 inhabitants per day. The fit of models and the degree of ecological association between antibiotic use and resistance data were assessed using generalised linear mixed models. RESULTS: Of 2204 patients included, H pylori resistance rates for adults were 17.5% for clarithromycin, 14.1% for levofloxacin and 34.9% for metronidazole, and were significantly higher for clarithromycin and levofloxacin in Western/Central and Southern Europe (>20%) than in Northern European countries (
OriginalsprogEngelsk
TidsskriftGut (English Edition)
Vol/bind62
Udgave nummer1
Sider (fra-til)34-42
Antal sider8
ISSN0017-5749
DOI
StatusUdgivet - jan. 2013

ID: 36444576